These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32924085)

  • 1. Importance of Ground-Glass Opacity in Long-Term Survivors of Lung Adenocarcinoma: A Leopard Cannot Change Its Spots.
    Ohtsuka T
    Ann Surg Oncol; 2021 Jan; 28(1):14-15. PubMed ID: 32924085
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
    Shigefuku S; Shimada Y
    Ann Surg Oncol; 2021 Jan; 28(1):157-158. PubMed ID: 33067744
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma.
    Shigefuku S; Shimada Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Ann Surg Oncol; 2021 Jan; 28(1):148-156. PubMed ID: 32920721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: Is sublobar resection enough for ground-glass opacity-dominant lung adenocarcinoma?
    Zhang Y; Chen H
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):303-304. PubMed ID: 33158561
    [No Abstract]   [Full Text] [Related]  

  • 5. Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients.
    Wang Y; Che G
    Ann Surg Oncol; 2021 Dec; 28(Suppl 3):841-842. PubMed ID: 34032962
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic Impact of Ground-Glass Opacity/Lepidic Component in Pulmonary Adenocarcinoma: A Hazy Staging Dilemma.
    Joubert P; Travis WD
    J Thorac Oncol; 2022 Jan; 17(1):19-21. PubMed ID: 34930607
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence Patterns and Patient Outcomes in Lung Adenocarcinoma Graded Clinical Stage II or Higher: Ground-Glass Opacity-Does It Matter?
    Qu R; Fu X
    Radiology; 2023 Aug; 308(2):e230754. PubMed ID: 37606574
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinicopathological study of lung adenocarcinomas with pure ground-glass opacity > 3 cm on high-resolution computed tomography.
    Sun K; Xie H; Zhao J; Wang B; Bao X; Zhou F; Zhang L; Li W
    Eur Radiol; 2022 Jan; 32(1):174-183. PubMed ID: 34132876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
    Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
    Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography density is not associated with pathological tumor invasion for pure ground-glass nodules.
    Fu F; Zhang Y; Wang S; Li Y; Wang Z; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):451-459.e3. PubMed ID: 32711984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y; Fu F; Chen H
    Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HRCT features differentiate synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases].
    Zhou LN; Wu N; Zhao SJ; Yang L; Wang YL; Wang RB; Yang SX
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):449-455. PubMed ID: 32575939
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiopathologic correlation of collision lung cancer with ground-glass opacity.
    Uchida S; Tsuta K; Kusumoto M; Shiraishi K; Kohno T; Watanabe SI
    Asian Cardiovasc Thorac Ann; 2019 Jan; 27(1):45-48. PubMed ID: 30417682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y; Jing L; Wang G
    J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From focal pulmonary pure ground-glass opacity nodule detected by low-dose computed tomography into invasive lung adenocarcinoma: A growth pattern analysis in the elderly.
    Nie X; Li L; Huang J; Zhang P; Shi H; Cheng G; Zhang YQ
    Thorac Cancer; 2018 Nov; 9(11):1361-1365. PubMed ID: 30144287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized texture analysis predicts histological invasiveness within lung adenocarcinoma manifesting as pure ground-glass nodules.
    Yang Y; Wang WW; Ren Y; Jin XQ; Zhu QD; Peng CT; Liu HQ; Zhang JH
    Acta Radiol; 2019 Oct; 60(10):1258-1264. PubMed ID: 30818977
    [No Abstract]   [Full Text] [Related]  

  • 18. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.
    Matsuguma H; Yokoi K; Anraku M; Kondo T; Kamiyama Y; Mori K; Tominaga K; Tsuura Y; Honjo S
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):278-84. PubMed ID: 12167787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computerized tomography-based radiomic model for assessing the invasiveness of lung adenocarcinoma manifesting as ground-glass opacity nodules.
    Zhu M; Yang Z; Wang M; Zhao W; Zhu Q; Shi W; Yu H; Liang Z; Chen L
    Respir Res; 2022 Apr; 23(1):96. PubMed ID: 35429974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to treat early-stage lung adenocarcinoma based on the size of the clinical solid component?
    Ma H; Zhang G
    Eur J Cardiothorac Surg; 2020 Sep; 58(3):662. PubMed ID: 32386206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.